ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SGTX Sigilon Therapeutics Inc

22.47
0.00 (0.00%)
May 02 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Sigilon Therapeutics Inc SGTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 22.47 19:00:00
Open Price Low Price High Price Close Price Previous Close
22.47 22.47
more quote information »

Recent News

Date Time Source Heading
8/21/202307:22EDGAR2Form 15-12G - Securities registration termination [Section..
8/15/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
8/14/202306:25PRNUSLilly Completes Acquisition of Sigilon Therapeutics
8/11/202315:28EDGAR2Form S-8 POS - Securities to be offered to employees in..
8/11/202315:20EDGAR2Form POS AM - Post-Effective amendments for registration..
8/11/202315:16EDGAR2Form 8-K - Current report
8/11/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/11/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/11/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202307:31EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
8/07/202307:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/01/202315:06EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
7/27/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/24/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/18/202315:03EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
7/13/202307:18EDGAR2Form SC 14D9 - Solicitation, recommendation statements
6/29/202306:35DJNEli Lilly to Acquire Sigilon Therapeutics
6/29/202306:03EDGAR2Form 8-K - Current report
6/29/202305:45PRNUSLilly to Acquire Sigilon Therapeutics
5/22/202306:30GLOBESigilon Announces Reverse Stock Split of Common Stock
5/09/202306:30GLOBESigilon Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock